Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ROSE II: Pilot Study to Analyze Menstrual Blood to Predict Endometriosis

NCT05601596 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.

NCT NCT05601596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05601596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ROSE II: Pilot Study to Analyze Menstrual Blood to Predict Endometriosis
Lead sponsor
Northwell Health
Phase
Observational
Overall status
Enrolling by invitation
Start date
May 27, 2022
Completion date
June 30, 2027
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometriosis